Home » Topics » Disease categories and therapies » Dental

Dental
RSS

Initiation of phase IV trial of Periostat and Atridox combination therapy

Jan. 9, 2003

Expanded indication for EmdogainGel in E.U.

Nov. 27, 2002

Atridox to be studied in chronic periodontitis/heart disease trial

July 16, 2002

FDA approves pivotal periodontal surgery trial of dermal substitute

July 11, 2002

Selective Lys-gingipain inhibitors for use in periodontitis

July 3, 2002

Periostat receives final marketing approvals in Portugal and The Netherlands

July 2, 2002

Platelet-derived growth factor evaluated in periodontal disease

May 31, 2002

Periostat approved in Israel

May 8, 2002

Periostat approved in Austria and Finland

April 26, 2002

MMP inhibitors with activity in animal model of periodontitis

April 2, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...
DEE-lightful: Praxis’ phase II results allow stock to flex its muscle
BioWorld
Positive efficacy results led to Praxis Precision Medicines Inc.’s phase II Embold study in developmental and epileptic encephalopathies (DEEs) being halted...